| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $11.1M | +24.4% |
| SG&A Expense | $9.1M | +47.6% |
| Operating Income | -$20.2M | -24.8% |
| Interest Expense | $7K | -1.5% |
| Pre-tax Income | -$19.8M | -25.3% |
| Net Income | -$19.8M | -25.4% |
| EPS (Basic) | -$1.49 | +14.9% |
| EPS (Diluted) | -$1.49 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $7.6M | -35.9% |
| Total Assets | $7.6M | -37.1% |
| Current Liabilities | $4.9M | +51.0% |
| Total Liabilities | $7.1M | +101.7% |
| Stockholders' Equity | $478K | -94.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.1M | -12.1% |
| Financing Cash Flow | $9.3M | -23.0% |
| +14.9% |